Results 141 to 150 of about 8,113 (209)

Aprocitentan in hypertension management: clinical efficacy, safety, and future prospects. [PDF]

Ann Med Surg (Lond)
Riaz R, Ahmed U, Naqi U, Afaq L, Shaukat A, Khan Y, Akilimali A.   +6 more
europepmc   +1 more source

Bosentan in pulmonary arterial hypertension: a comparison between congenital heart disease and chronic pulmonary embolism

, 2009
M. G. J. Duffels, Mart N. van der Plas, Sulaiman Surie, Michiel M. Winter, Berto J. Bouma, Maarten Groenink, Arie P.J. van Dijk, Elke S. Hoendermis, Rolf M.F. Berger, Paul Bresser, Barbara J.M. Mulder   +10 more
openalex   +2 more sources

Effects of Bosentan on Hypoxia, Inflammation and Oxidative Stress in Experimental Blunt Thoracic Trauma Model. [PDF]

Medicina (Kaunas)
Uzun N, Durmus S, Gercel G, Aksu B, Misirlioglu NF, Uzun H.   +5 more
europepmc   +1 more source

Treatment of Buerger disease (thromboangiitis obliterans) with bosentan: a case report

, 2009
Joaquín De Haro, A. Florez, José Luis Fernández, Francisco Acín   +3 more
openalex   +2 more sources

Pulmonary Hypertension Associated with Interstitial Lung Disease (PH-ILD): Back to the Future. [PDF]

Adv Ther
Fiorentù G, Bernardinello N, Giulianelli G, Cocconcelli E, Balestro E, Spagnolo P.   +5 more
europepmc   +1 more source

Bosentan in Pediatric Patients with Pulmonary Arterial Hypertension

, 2009
Maurice Beghetti
openalex   +2 more sources

Safety, tolerability, and efficacy of an in-class combination therapy switch from bosentan plus sildenafil to ambrisentan plus tadalafil in children with pulmonary arterial hypertension. [PDF]

Pulm Circ
Morgan C, Idris N, Elterefi K, Di Ienno L, Constantine A, Quyam S, Bini R, Moledina S.   +7 more
europepmc   +1 more source

An in-depth evaluation of the efficacy and safety of various treatment modalities for chronic thromboembolic pulmonary hypertension: A systematic review and network meta-analysis. [PDF]

Am Heart J Plus
Ismail NR, Makhlouf HA, Hassan A, Elshahat A, Abdellatif MA, Rezk AE, Mady A, Mohamed RG, Elfeky HM, Abdelaziz A.   +9 more
europepmc   +1 more source

The Cost-Effectiveness of Bosentan in the United Kingdom for Patients with Pulmonary Arterial Hypertension of WHO Functional Class III

, 2009
Matt Stevenson, Frances C. Macdonald, Jonathan Langley, Elke Hunsche, Ron Akehurst   +4 more
openalex   +1 more source

Fundamental and Targeted Approaches in Pulmonary Arterial Hypertension Treatment. [PDF]

Pharmaceutics
Park JS, Choi YH, Min JY, Lee J, Shim G.
europepmc   +1 more source